A detailed history of Abel Hall, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Abel Hall, LLC holds 1,550 shares of JNJ stock, worth $240,513. This represents 0.16% of its overall portfolio holdings.

Number of Shares
1,550
Holding current value
$240,513
% of portfolio
0.16%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$145.48 - $167.38 $225,493 - $259,439
1,550 New
1,550 $251 Million
Q1 2024

May 08, 2024

BUY
$155.22 - $162.74 $204,890 - $214,816
1,320 New
1,320 $209 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Abel Hall, LLC Portfolio

Follow Abel Hall, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abel Hall, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abel Hall, LLC with notifications on news.